All In Biotech

Drug Trial Radar · NCT03791775

Efficacy and Safety of Polidocanol Foam 3% in the Treatment of II Degree Hemorrhoidal Disease

A Multicentre, Open-label, Single-arm Phase II Trial on the Efficacy and Safety of Sclerotherapy Using 3% Polidocanol Foam to Treat Second-degree Hemorrhoidal Disease

Last checked: Nov 20, 2026Latest source record: Sep 17, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

183

Actual

Start

Jan 2, 2019

Primary completion

Jun 2, 2019

Study completion Jun 2, 2020

Sponsor

Lead sponsor
Societa Italiana di Chirurgia ColoRettaleResearch network
Sponsor type
Research network
Collaborators
SICCR - Gaetano Gallo
First posted
Jan 3, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Hemorrhoidal disease (HD) is one of the oldest and most common proctologic diseases that has been described with an estimated prevalence between 4.4% and 86%. Despite the proposal of three mechanisms that might underlie haemorrhoidal development - the varicose vein theory, the vascular hyperplasia theory and the sliding anal-lining theory, the exact pathophysiology of symptomatic hemorrhoid disease is poorly understood. HD seems to be the most common cause for rectal bleeding, or hematochezia, and the second most frequent cause for severe rectorrhagia after diverticulitis. The blood is bright red and coats the stool at the end of defection. Other symptoms include pain, mucous discharge, itching or the sensation of tissue prolapse. The most widely accepted classification is the Goligher classification: * Grade I: hemorrhoids bleed but do not prolapse out of the anal canal; * Grade II: hemorrhoidal cushions prolapse outside of the anal canal on straining or during bowel movements, but reduce spontaneously; * Grade III: hemorrhoidal cushions prolapse outside the anal canal on straining and require manual reduction; * Grade IV: hemorrhoidal prolapse is irreducible even with manipulation

Conditions

  • Second-degree Hemorrhoids

Interventions

  • Polidocanol foam (Atossisclerol® 3%)Drug

    The procedure will be performed in the Sims position or lithotomy position. A modified Blonde-Blanchard technique will be adopted, with the tangential injection of polidocanol foam into the submucosa of the apex of each hemorrhoidal pile, without exceeding three piles, and using a self-lighting open-ended anoscope and a 20-G needle in order to reduce bleeding

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Success Rate 1Time frame: 12 months follow-up

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Catanzaro

    Catanzaro, Italy

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.